Husain Matloob, Moss Bernard
Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892-0445, USA.
J Virol. 2003 Aug;77(16):9008-19. doi: 10.1128/jvi.77.16.9008-9019.2003.
The F13L protein of vaccinia virus, an essential and abundant palmitoylated peripheral membrane component of intra- and extracellular enveloped virions, associates with Golgi, endosomal, and plasma membranes in the presence or absence of other viral proteins. In the present study, the trafficking of a fully functional F13L-green fluorescent protein (GFP) chimera in transfected and productively infected cells was analyzed using specific markers and inhibitors. We found that Sar1(H79G), a trans-dominant-negative protein inhibitor of cargo transport from the endoplasmic reticulum, had no apparent effect on the intracellular distribution of F13L-GFP, suggesting that the initial membrane localization occurs at a downstream compartment of the secretory pathway. Recycling of F13L-GFP from the plasma membrane was demonstrated by partial colocalization with FM4-64, a fluorescent membrane marker of endocytosis. Punctate F13L-GFP fluorescence overlapped with clathrin and Texas red-conjugated transferrin, suggesting that endocytosis occurred via clathrin-coated pits. The inhibitory effects of chlorpromazine and trans-dominant-negative forms of dynamin and Eps15 protein on the recycling of F13L-GFP provided further evidence for clathrin-mediated endocytosis. In addition, the F13L protein was specifically coimmunoprecipitated with alpha-adaptin, a component of the AP-2 complex that interacts with Eps15. Nocodazole and wortmannin perturbed the intracellular trafficking of F13L-GFP, consistent with its entry into late and early endosomes through the secretory and endocytic pathways, respectively. The recycling pathway described here provides a mechanism for the reutilization of the F13L protein following its deposition in the plasma membrane during the exocytosis of enveloped virions.
痘苗病毒的F13L蛋白是细胞内和细胞外被膜病毒粒子中一种必需且丰富的棕榈酰化外周膜成分,无论有无其他病毒蛋白存在,它都能与高尔基体、内体和质膜结合。在本研究中,使用特异性标记物和抑制剂分析了功能性F13L-绿色荧光蛋白(GFP)嵌合体在转染和有效感染细胞中的运输情况。我们发现,Sar1(H79G)是一种从内质网运输货物的反式显性负性蛋白抑制剂,对F13L-GFP的细胞内分布没有明显影响,这表明初始膜定位发生在分泌途径的下游区室。通过与FM4-64(一种内吞作用的荧光膜标记物)部分共定位,证明了F13L-GFP从质膜的循环利用。点状F13L-GFP荧光与网格蛋白和德克萨斯红偶联的转铁蛋白重叠,表明内吞作用是通过网格蛋白包被小窝发生的。氯丙嗪以及显性负性形式的发动蛋白和Eps15蛋白对F13L-GFP循环利用的抑制作用为网格蛋白介导的内吞作用提供了进一步证据。此外,F13L蛋白与α-衔接蛋白特异性共免疫沉淀,α-衔接蛋白是与Eps15相互作用的AP-2复合物的一个组分。诺考达唑和渥曼青霉素扰乱了F13L-GFP的细胞内运输,这分别与其通过分泌途径进入晚期内体和通过内吞途径进入早期内体一致。这里描述的循环途径为包膜病毒粒子胞吐过程中F13L蛋白沉积在质膜后重新利用提供了一种机制。